Monopar Therapeutics Inc. buy Midas
Start price
24.10.20
/
50%
€4.00
Target price
04.11.21
-
Performance (%)
37.50%
End price
26.01.21
€5.50
Summary
This prediction ended on 26.01.21 with a price of €5.50. The BUY prediction by Midas for Monopar Therapeutics Inc. saw massive gains of 37.50%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by Midas for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.